Feb 28, 2020
Logan chats with Dr. Joel Diamond about the value of using genetic and genomic testing to make real-time diagnoses and treatment decisions and how these tests can positively affect the outcomes and treatment paths for a variety of medical conditions. Logan also talks with Ken Rubin of BPM + Health about how building a community comprised of different levels of patient providers can help deliver a better standard of care. The following companies, all of whom are exhibiting at HIMSS 2020 sponsored this episode: Ōmcare (omcare.com), changing the way the world cares with its Ōmcare Home Health Hub™; Fujitsu Computer Products of America (fcpa.com/us) the leader in document imaging and scanning, offering a full range of scanning technologies and solutions; 2bPrecises (2bprecisehealth.com) helping healthcare organizations leverage the full value of genetic and genomic testing; BPM+ Health (bpm-plus.org), a community that brings together CMIOs from hospitals and healthcare systems, industry and physician associations, vendors, and consultants to create machine-readable clinical pathways that can be shared across healthcare systems; TouchPoint Medical (touchpointmed.com), which designs, manufactures, and sells medical equipment around the world that mobilizes medical technology and manages medication dispensing; and Bridge Patient Portal (bridgepatientportal.com), a company that revolutionizes the patient experience by giving users access to an unprecedented set of tools and services to manage their care through a “single pane of glass.”